SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000728889-17-000324
Filing Date
2017-02-14
Accepted
2017-02-14 13:05:32
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G celldextherapeuticsinc3.htm SC 13G/A 20010
  Complete submission text file 0000728889-17-000324.txt   21964
Mailing Address 225 LIBERTY STREET NEW YORK NY 10281-1008
Business Address 225 LIBERTY STREET NEW YORK NY 10281-1008 212-323-0200
OppenheimerFunds, Inc. (Filed by) CIK: 0000728889 (see all company filings)

IRS No.: 000000000 | State of Incorp.: CO | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 0000

Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Subject) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-37761 | Film No.: 17606179
SIC: 2835 In Vitro & In Vivo Diagnostic Substances